Previous Close | 42.64 |
Open | 42.57 |
Bid | 42.77 x 900 |
Ask | 43.93 x 1000 |
Day's Range | 42.53 - 43.32 |
52 Week Range | 34.74 - 47.70 |
Volume | |
Avg. Volume | 1,003,130 |
Market Cap | 9.597B |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | 28.46 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.28 (2.94%) |
Ex-Dividend Date | Jan 30, 2024 |
1y Target Est | N/A |
QIAGEN's (QGEN) next-generation sequencing test aims to aid personalized medicine research in solid tumor types, including ovarian cancer, and improve decentralized testing capabilities.
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Key Insights Qiagen's estimated fair value is US$43.31 based on 2 Stage Free Cash Flow to Equity Qiagen's US$45.02...